There’s a medically approved cannabis-based treatment called Sativex, but it doesn’t work for everyone. In England, Wales and Northern Ireland it’s approved for use on the NHS for ‘moderate’ to ‘severe’ spasticity (muscle spasms and stiffness). But you can have it only if other treatments haven’t worked. It’s not yet approved in Scotland but we hope it soon will be.
In November 2018, the UK government legalised cannabis for medicinal use, but also put a strict criteria in place for who could access it. Only specialist doctors are allowed to prescribe medicinal cannabis, and so far only a handful of people have benefited from the change in law.
One in five people with multiple sclerosis (MS) surveyed in 2014 told us they’d used cannabis to help with their symptoms. They said it can help with muscle spasms or stiffness (spasticity) and pain.
Cannabis is made up of compounds called cannabinoids. The main ones studied for their therapeutic effect are tetrahydrocannabinol (THC), which gets you ‘high’, and cannabidiol (CBD), which doesn’t.
Some people with MS use cannabis in a variety of ways to help ease their symptoms.
Frontiers in Neurology: “Cannabidiol to Improve Mobility in People with Multiple Sclerosis.”
Harvard Medical School: “Cannabidiol (CBD) — what we know and what we don’t.”
CBD oil is a common way to take it. You can put it under your tongue or add it to your food or drinks. You can also put it on your skin. Some research found sprays you put under your tongue might be best for MS.
What to Watch For
Possible side effects may include:
Experts say taking 300 milligrams a day by mouth for up to 6 months might be safe. Taking 1,500 milligrams per day by mouth for up to 1 month may be OK, too. People have used 2.5-milligram sprays under their tongue for up to 2 weeks.
The FDA hasn’t approved CBD to treat multiple sclerosis, or MS. Studies are ongoing, but the evidence is mixed. Here’s what we know.
FDA: “FDA Regulation of Cannabis and Cannabis-Derived Products, Including Cannabidiol (CBD).”